{"id":"W1975313529","doi":"10.1016/s1556-0864(15)31641-5","title":"Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Cell Lung Cancer: A Systematic Review and Practice Guideline","year":2006,"lang":"en","type":"review","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Cancer Care Ontario; Juravinski Cancer Centre; Sudbury Regional Hospital","funders":"","keywords":"Docetaxel; Medicine; Internal medicine; Erlotinib; Pemetrexed; Oncology; Lung cancer; Gefitinib; Topotecan; Febrile neutropenia; Afatinib; Guideline; Regimen; Vinorelbine; Chemotherapy; Cancer; Neutropenia; Epidermal growth factor receptor; Pathology; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002229263,0.0006034217,0.006612209,0.0003120072,0.0001006732,0.00004158717,0.0002555916,0.0003962542,0.0001451078],"category_scores_gemma":[0.0008176412,0.0002934233,0.0007236836,0.0003488694,0.00005458268,0.0001347419,0.00004203432,0.0006153429,0.000003131368],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002265113,"about_ca_system_score_gemma":0.008210871,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001243466,"about_ca_topic_score_gemma":0.00004150043,"domain_scores_codex":[0.9944389,0.0008489375,0.003604645,0.0004089928,0.0003195275,0.0003789766],"domain_scores_gemma":[0.9880402,0.001562916,0.007931001,0.0003944588,0.001802269,0.0002691536],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00124143,0.0005637949,5.655957e-7,0.7338839,0.002530319,0.0008437986,0.0001098493,7.597903e-7,7.596564e-7,0.000001173632,0.01704798,0.2437757],"study_design_scores_gemma":[0.001215073,0.004064492,1.161905e-7,0.3950977,0.0654581,0.01648371,0.00008513687,0.000009157357,0.00000132191,0.000001122674,0.5174077,0.0001763329],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000008691919,0.9814305,0.0003518629,0.001782421,0.0009206916,0.0150415,0.000229971,0.00001554891,0.0002188758],"genre_scores_gemma":[0.000003987959,0.9826726,0.008943558,0.0013873,0.0009018483,0.00279272,0.0001328102,0.00009419936,0.003070961],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5003597,"threshold_uncertainty_score":0.9999518,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07230581937056216,"score_gpt":0.5353964829965041,"score_spread":0.463090663625942,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}